These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 24860432)

  • 1. The role of oxidative stress in degeneration of the neuromuscular junction in amyotrophic lateral sclerosis.
    Pollari E; Goldsteins G; Bart G; Koistinaho J; Giniatullin R
    Front Cell Neurosci; 2014; 8():131. PubMed ID: 24860432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Clark JA; Southam KA; Blizzard CA; King AE; Dickson TC
    J Chem Neuroanat; 2016 Oct; 76(Pt A):35-47. PubMed ID: 27038603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HuD (ELAVL4) gain-of-function impairs neuromuscular junctions and induces apoptosis in in vitro and in vivo models of amyotrophic lateral sclerosis.
    Silvestri B; Mochi M; Mawrie D; de Turris V; Colantoni A; Borhy B; Medici M; Anderson EN; Garone MG; Zammerilla CP; Pandey UB; Rosa A
    bioRxiv; 2024 Mar; ():. PubMed ID: 38464028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of Glial Cell at the Neuromuscular Junction Are Incompatible with Synaptic Repair in the
    Martineau É; Arbour D; Vallée J; Robitaille R
    J Neurosci; 2020 Sep; 40(40):7759-7777. PubMed ID: 32859714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homocysteine aggravates ROS-induced depression of transmitter release from motor nerve terminals: potential mechanism of peripheral impairment in motor neuron diseases associated with hyperhomocysteinemia.
    Bukharaeva E; Shakirzyanova A; Khuzakhmetova V; Sitdikova G; Giniatullin R
    Front Cell Neurosci; 2015; 9():391. PubMed ID: 26500495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposite Synaptic Alterations at the Neuromuscular Junction in an ALS Mouse Model: When Motor Units Matter.
    Tremblay E; Martineau É; Robitaille R
    J Neurosci; 2017 Sep; 37(37):8901-8918. PubMed ID: 28821658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender-Specific Mechanism of Synaptic Impairment and Its Prevention by GCSF in a Mouse Model of ALS.
    Naumenko N; Pollari E; Kurronen A; Giniatullina R; Shakirzyanova A; Magga J; Koistinaho J; Giniatullin R
    Front Cell Neurosci; 2011; 5():26. PubMed ID: 22180738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative Stress as a Therapeutic Target in Amyotrophic Lateral Sclerosis: Opportunities and Limitations.
    Park HR; Yang EJ
    Diagnostics (Basel); 2021 Aug; 11(9):. PubMed ID: 34573888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MG53 Preserves Neuromuscular Junction Integrity and Alleviates ALS Disease Progression.
    Yi J; Li A; Li X; Park K; Zhou X; Yi F; Xiao Y; Yoon D; Tan T; Ostrow LW; Ma J; Zhou J
    Antioxidants (Basel); 2021 Sep; 10(10):. PubMed ID: 34679657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sporadic amyotrophic lateral sclerosis (SALS) - skeletal muscle response to cerebrospinal fluid from SALS patients in a rat model.
    Shanmukha S; Narayanappa G; Nalini A; Alladi PA; Raju TR
    Dis Model Mech; 2018 Apr; 11(4):. PubMed ID: 29666144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromuscular junction protection for the potential treatment of amyotrophic lateral sclerosis.
    Krakora D; Macrander C; Suzuki M
    Neurol Res Int; 2012; 2012():379657. PubMed ID: 22919482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyotrophic lateral sclerosis-immunoglobulins selectively interact with neuromuscular junctions expressing P/Q-type calcium channels.
    Gonzalez LE; Kotler ML; Vattino LG; Conti E; Reisin RC; Mulatz KJ; Snutch TP; Uchitel OD
    J Neurochem; 2011 Nov; 119(4):826-38. PubMed ID: 21883225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromuscular Junction Impairment in Amyotrophic Lateral Sclerosis: Reassessing the Role of Acetylcholinesterase.
    Campanari ML; García-Ayllón MS; Ciura S; Sáez-Valero J; Kabashi E
    Front Mol Neurosci; 2016; 9():160. PubMed ID: 28082868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutathione S-Transferase Rescues Motor Neuronal Toxicity in Fly Model of Amyotrophic Lateral Sclerosis.
    Cha SJ; Han YJ; Choi HJ; Kim HJ; Kim K
    Antioxidants (Basel); 2020 Jul; 9(7):. PubMed ID: 32674363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired Mitophagy Plays a Role in Denervation of Neuromuscular Junctions in ALS Mice.
    Rogers RS; Tungtur S; Tanaka T; Nadeau LL; Badawi Y; Wang H; Ni HM; Ding WX; Nishimune H
    Front Neurosci; 2017; 11():473. PubMed ID: 28890682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative Stress in Amyotrophic Lateral Sclerosis: Pathophysiology and Opportunities for Pharmacological Intervention.
    Cunha-Oliveira T; Montezinho L; Mendes C; Firuzi O; Saso L; Oliveira PJ; Silva FSG
    Oxid Med Cell Longev; 2020; 2020():5021694. PubMed ID: 33274002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory synaptic regulation of motoneurons: a new target of disease mechanisms in amyotrophic lateral sclerosis.
    Martin LJ; Chang Q
    Mol Neurobiol; 2012 Feb; 45(1):30-42. PubMed ID: 22072396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR126-5p Downregulation Facilitates Axon Degeneration and NMJ Disruption via a Non-Cell-Autonomous Mechanism in ALS.
    Maimon R; Ionescu A; Bonnie A; Sweetat S; Wald-Altman S; Inbar S; Gradus T; Trotti D; Weil M; Behar O; Perlson E
    J Neurosci; 2018 Jun; 38(24):5478-5494. PubMed ID: 29773756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of Impaired BDNF Signaling, Their Coupled Downstream Serine-Threonine Kinases and SNARE/SM Complex in the Neuromuscular Junction of the Amyotrophic Lateral Sclerosis Model SOD1-G93A Mice.
    Just-Borràs L; Hurtado E; Cilleros-Mañé V; Biondi O; Charbonnier F; Tomàs M; Garcia N; Lanuza MA; Tomàs J
    Mol Neurobiol; 2019 Oct; 56(10):6856-6872. PubMed ID: 30929165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-disease comparison of amyotrophic lateral sclerosis and spinal muscular atrophy reveals conservation of selective vulnerability but differential neuromuscular junction pathology.
    Comley LH; Nijssen J; Frost-Nylen J; Hedlund E
    J Comp Neurol; 2016 May; 524(7):1424-42. PubMed ID: 26502195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.